October 22-24, 2012
Washington, DC
Special Challenges in Rare Diseases
- Learn how the government and private sector are addressing the special challenges faced by patients and companies in the new health care environment
- Meet individuals who face the same challenges that you do
- Gain a better understanding of how the FDA and NIH work and how they interact with the drug and device development processes
- Learn ways to de-risk your investments in orphan products and understand better the timelines for research and regulatory reviews
Keynote:
- John J. Castellani: President & CEO Pharmaceutical Research and Manufacturers of America (PhRMA)
|
Meeting Program
No comments:
Post a Comment